RecruitingNCT05169541

Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction

Is Plasma Level of Mannose Binding Lectin Associated With Reproductive Failure?

Sponsor

Aalborg University Hospital

Enrollment

500 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Recurrent miscarriage Recurrent implantation failure Mannose binding lectin deficiency Infertility Recurrent Pregnancy Loss Habitual Abortion Recurrent Spontaneous Abortion

Summary

A low plasma level of mannose binding lectin (p-MBL) is associated with unexplained recurrent pregnancy loss (RPL), but it is not investigated if it is associated with unexplained reproductive failure in general, including recurrent implantation failure (RIF) after assisted reproductive technology (ART) (including IVF, ICSI and FET), recurrent pregnancy loss (RPL) after spontaneous conception, and RPL after ART.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 41 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with habitual abortion, infertility, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 41 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.